Publications

In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against &#223-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS)., Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA), Lead author: Chin JN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile, Lead author: Tang D, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Omiganan Pentahydrochloride against Yeast and Mould Pathogens Associated with Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Medium Quality and Susceptibility Testing Results of Telavancin Using CLSI Standardized Methods (M2-A9 and M7-A7), Lead author: Benton BM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Antimicrobial Activity of Doripenem Tested Against Bloodstream Infection Isolates from North America (2003-2006), Lead author: Fritsche TR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Five-Year Longitudinal Assessment of Linezolid (LZD) Activity in Europe (EU): Results from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS), Lead author: Ross JE, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Secular Trends in Antimicrobial Resistance Among USA Isolates of S. pneumoniae : A Decade of Experience from the SENTRY Antimicrobial Surveillance Program, Lead author: Moet G, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Differential Potential for the Disinfectant Benzalkonium Chloride and the Antiseptics Chlorhexidine and Omiganan Pentahydrochloride to Serve as Resistance Selectors in the Hospital Environment, Lead author: Johnson DM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp., Lead author: Killian SB, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

A Multi-Site Study of a Broth D Zone Test System Using TREK Sensititre® 18-24 hour dried Susceptibility Plates for Detecting Inducible Resistance to Clindamycin in Macrolide Resistant Gram-Positive Organisms, Lead author: Miskov AM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants, Lead author: Jones RN, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide, Lead author: Biedenbach DJ, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method, Lead author: Rhomberg PR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Molecular Analysis of Resistance Markers and Clonality among Gram-negative Bacilli: Report from the 2006 MYSTIC Program (USA), Lead author: Deshpande LM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Community-Acquired Respiratory Tract Infections (CA-RTI) in Europe Caused by S. pneumoniae (SPN), H. influenzae (HI) and M. catarrhalis (MCAT): Report from 10 Years of Monitoring by the SENTRY Program, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Increasing Prevalence of Glycopeptide Hetero-resistant S. aureus (hGISA) from the Detroit Metropolitan Area over a 20-year period (1986-2006), Lead author: Rybak M, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Linezolid Against a Worldwide Collection of Uncommonly Isolated Gram-positive Organisms (3,251 strains), Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Differential Propensity of Serotype Groups to Switch and Acquire Multidrug-Resistance after the Introduction of the Pneumococcal Conjugate Vaccine in the United States, Lead author: Mera RM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

10 Years of Surveillance of Bloodstream Infections in European Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Occurrence and Susceptibility (S) Rates Among Urinary Tract Infection Pathogens from Europe: A Seven Year Report from the SENTRY Antimicrobial Surveillance Program (1997-2000, 2003), Lead author: Moet G, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated in Two Turkish Medical Centers in 2006: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Accuracy of Beta-Lactam Susceptibility Testing Results from Vitek and Vitek 2 Systems when Testing Pseudomonas aeruginosa, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Critical Assessment of P. aeruginosa (PSA) Susceptibility Testing Results for Six Beta-Lactams Using the BD Phoenix System, Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

An Evaluation of MicroScan WalkAway Results for Broad-Spectrum Beta-Lactams When Testing Pseudomonas aeruginosa (PSA), Lead author: Jones RN, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Evaluation of the In Vitro Activity of Levofloxacin and Moxifloxacin Tested Against Stenotrophomonas maltophilia: Can Moxifloxacin Activity Be Predicted by Levofloxacin MIC Results?, Lead author: Gales AC, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Susceptibility Analysis of Gastroenteritis and Beta-Haemolytic Streptococcal Pathogens Collected During a Decade of SENTRY Antimicrobial Surveillance Program Monitoring in Europe (1997-2006), Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence and Antimicrobial Susceptibility (S) Profiles of Skin and Skin Structure Infection (SSSI) Pathogens in Europe (EUR): Report from the SENTRY Antimicrobial Surveillance Program (1997-2005), Lead author: Ross JE, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Resistance Rates Among Selected Gram-positive and -negative Isolates from European (EU) Medical Centers: A Decade of SENTRY Program Surveillance (1997-2006), Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Update on Potency and Spectrum of Activity of Meropenem (MEM) and Selected Broad-Spectrum Agents: Testing Results from the USA MYSTIC Program (2006), Lead author: Rhomberg PR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Update on Daptomycin Activity and Spectrum When Tested Against Gram-Positive Strains Collected in European Medical Centers (2006), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Daptomycin and Selected Antimicrobial Agents Tested against Gram-positive Organisms Isolated from European Patients with Complicated Skin and Skin Structure Infections (cSSSI), Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Trends in Species Distributions and Susceptibilities of Fungal Pathogens Recovered from European Medical Centers: A Report from the SENTRY Antimicrobial Surveillance Program (1999-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bacterial Isolates Collected in European Hospitals in 2006, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Evaluation of Expected Clinical Success Rates of Tigecycline and Other Commonly Used Antimicrobials for Empiric Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in Germany, Spain and the United States, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Spectrum and Activity of Doripenem, an Investigational Carbapenem, Tested Against Bacterial Pathogens Recovered from Patients Hospitalized with Pneumonia (Europe; 2004-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Variations and Trends in the Activity of Doripenem and Other Broad-Spectrum Agents Against Leading Bacterial Pathogens: Results from a European Surveillance Program (2003-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence of Confirmed ESBL-Production among European Enterobacteriaceae: A Ten Year Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Emergence and Dissemination of Metallo-Beta-Lactamases Producing Strains in Europe: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Assessment of the Polymyxin B Antimicrobial Activity Tested against 26,921 Clinical Strains of Gram-Negative Bacilli Collected in Europe: Report from 10 Years of the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Characterization VIM-1-Producing Pseudomonas aeruginosa, Enterobacter cloacae and Klebsiella pneumoniae Strains from Germany: Report from SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

The Evaluation of the Bactericidal Activity of Daptomycin, Vancomycin and Linezolid and determination of the Interactions of These Antimicrobials with Gentamicin or Rifampin against S. aureus, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence and Antimicrobial Susceptibility Profiles of Leading Nosocomial Pneumonia Pathogens: The Ten Year Report from the European SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

High-Level Multidrug-Resistance (MDR) Among Viridians Group Streptococci Isolated from Turkey: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Staphylococcal and Streptococcal Isolates Recovered from Patients in European Medical Centers (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany